322 related articles for article (PubMed ID: 25637953)
21. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
24. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL).
Kalka C; Spirk D; Siebenrock KA; Metzger U; Tuor P; Sterzing D; Oehy K; Wondberg D; Mouhsine el Y; Gautier E; Kucher N
Thromb Haemost; 2009 Jul; 102(1):56-61. PubMed ID: 19572068
[TBL] [Abstract][Full Text] [Related]
25. Aggressive venous thromboembolism prophylaxis reduces VTE events in vascular surgery patients.
Durinka JB; Hecht TE; Layne AJ; Jackson BM; Woo EY; Fairman RM; Rohrbach JI; Wang GJ
Vascular; 2016 Jun; 24(3):233-40. PubMed ID: 26123057
[TBL] [Abstract][Full Text] [Related]
26. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
[TBL] [Abstract][Full Text] [Related]
27. Extended duration chemoprophylaxis for venous thromboembolism following abdominopelvic oncologic surgery.
Kanitra J; Holtrop J; Jawad A; Berri R
J Thromb Thrombolysis; 2020 Jul; 50(1):190-194. PubMed ID: 31786714
[TBL] [Abstract][Full Text] [Related]
28. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
29. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry.
Bergqvist D; Arcelus JI; Felicissimo P;
Thromb Haemost; 2012 Feb; 107(2):280-7. PubMed ID: 22186771
[TBL] [Abstract][Full Text] [Related]
30. Is extended thromboprophylaxis necessary in elective colorectal cancer surgery?
Chandra R; Melino G; Thomas M; Lawrence MJ; Hunter RA; Moore J
ANZ J Surg; 2013 Dec; 83(12):968-72. PubMed ID: 23802729
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic use of anticoagulation and hemodilution for the prevention of venous thromboembolic events following meningioma surgery.
Moussa WM; Mohamed MA
Clin Neurol Neurosurg; 2016 May; 144():1-6. PubMed ID: 26945875
[TBL] [Abstract][Full Text] [Related]
32. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study.
Bergqvist D; Arcelus JI; Felicissimo P;
Thromb Haemost; 2012 Feb; 107(2):270-9. PubMed ID: 22186708
[TBL] [Abstract][Full Text] [Related]
34. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
35. Maximizing chemoprophylaxis against venous thromboembolism in abdominoplasty patients with the use of preoperative heparin administration.
Campbell W; Pierson J; Cohen-Shohet R; Mast BA
Ann Plast Surg; 2014; 72(6):S94-6. PubMed ID: 24691325
[TBL] [Abstract][Full Text] [Related]
36. Venous thromboembolism prophylaxis in neurosurgical trauma patients.
Tracy BM; Dunne JR; O'Neal CM; Clayton E
J Surg Res; 2016 Sep; 205(1):221-7. PubMed ID: 27621023
[TBL] [Abstract][Full Text] [Related]
37. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism.
Strom RG; Frempong-Boadu AK
Spine (Phila Pa 1976); 2013 Nov; 38(23):E1498-502. PubMed ID: 23873245
[TBL] [Abstract][Full Text] [Related]
38. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
[TBL] [Abstract][Full Text] [Related]
39. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
Dranitsaris G; Stumpo C; Smith R; Bartle W
Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
[TBL] [Abstract][Full Text] [Related]
40. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T
JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
